Study: Estrogen patch less risky than pillJane E. Allen, Los Angeles Times
When it comes to assessing the risk of estrogen therapy for menopause, how the therapy is delivered--taking a pill versus wearing a patch on one's skin--doesn't affect risk or benefit, researchers at UCLA and elsewhere have found. Study Assesses Dose and Delivery Method for Menopause HRT ...
Women ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today inHypertension, a peer-reviewed American Heart As...
suppress endometriosis-associated pain. Therefore, we use the LNG-IUS with an oralprogestinor estrogen/progestin pill and not the LNG-IUS alone.74When counseling on the LNG-IUS, we offer patients its placement at time of laparoscopy, to eliminate the possible insertional pain in the outpatient...
Based on this rationale, clinical trials are currently ongoing or are ready to start, to evaluate the effect of estrogen treatment of COVID-19. A phase 2 study has been started to test if E2 delivered via a transdermal patch can reduce the severity of COVID-19 symptoms compared to regular...
the PILL and NONE groups. Less robust differences between groups were seen at the distal radius, where percent change in cortical area and thickness was significantly greater in the PATCH vs. PILL and NONE groups, and changes in cortical vBMD were significantly greater in the PATCH vs. PILL ...